32193-95-6

Basic information

• Product Name: 4-(4-Fluorophenyl)benzyl chloride
• Synonyms: 4-(4-Fluorophenyl)benzyl chloride;4-(chloromethyl)-4-fluoro-1,1-biphenyl
• CAS NO: 32193-95-6
• Molecular Formula: C13H10ClF
• Molecular Weight: 220.6699032
• Mol File: 32193-95-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-Fluorophenyl)benzyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-Fluorophenyl)benzyl chloride(32193-95-6)
• EPA Substance Registry System: 4-(4-Fluorophenyl)benzyl chloride(32193-95-6)

Safety Data

• Hazardous Substances Data: 32193-95-6(Hazardous Substances Data)

Upstream product

• 147497-56-1 (4'-Fluoro-biphenyl-4-yl)-methanol 
• 1765-93-1 4-fluoroboronic acid 
• 589-17-3 p-bromobenzyl chloride 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Compounds that modulate PPAR activity and methods for their preparation

This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as methods of supressing appetite and modulating leptin levels in a mammal. The present invention also discloses methods for making the disclosed compounds.